Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 395

The DOI matches its Crossref record.

STAPHYLOCOCCUS AUREUS RESISTANT TO VANCOMYCIN???UNITED STATES, 2002

&NA;·2002·Infectious Diseases in Clinical Practice

Abstract

STAPHYLOCOCCUS AUREUS RESISTANT TO VANCOMYCIN—UNITED STATES, 2002 [CDC MMWR 2002;51:565]: The patient is a 40-year-old diabetic on renal dialysis from Michigan who had multiple foot infections treated with vancomycin and other antibiotics from April 2001 until April 2002 when he underwent amputation of a toe and then developed infection involving MRSA bacteremia at the site of the hemodialysis graft. The graft was removed and cultures from the catheter tip and exit site yielded S. aureus with an MIC to oxacillin >32 mcg/ml and to vancomycin of >128 mcg/ml. Analysis of this strain showed it contained vanA resistance gene from enterococci. Comment: This is the first reported clinical isolate of S. aureus that is fully resistant to vancomycin. VRE has been known for many years and resistance to vancomycin in these strains has been attributed to resistant determinants vanA, B, D, E, F and G. The fear was that this resistance gene would be transferred from the enterococcus, a microbe with little pathogenic clout, to S. aureus, which has substantial pathogenic potential. Strains of S. aureus that are relatively resistant to vancomycin (vancomycin—intermediately resistant S. aureus, VISA) were originally reported from Japan (Lancet 1997;350:1670) and were subsequently reported in the US (MMWR 2000;48:1165;NEJM 1999;340:517;NEJM 1999;340:493). These strains did not contain the vancomycin-resistant gene from the enterococcus, they had MICs <16 mcg/ml to vancomycin, there was no widespread dissemination of VISA in the US (J Clin Microbiol 1999;37:3590), and these strains mysteriously almost disappeared from Japan (J Clin Microbiol 2001;39:4445). The S. aureus in the case report summarized above is very different because it is highly resistant to vancomycin and contains the vanA gene from VRE. Transfer of this resistance mechanism from VRE to S. aureus has been shown in vitro and in experimental animals, but never in people (Microb M Drug Resist 2001;7:229;FEMS Microbiol Lett 1992;93:195). This strain represents what authorities in antibiotic resistance have feared the most: the vancomycin-resistant gene from the enterococcus in S. aureus. The good news in this otherwise morbid observation is that both this strain of S. aureus and nearly all strains of VRE are susceptible to linezolid. This isolate of VRSA also proved susceptible to quinupristin/dalfopristin (Synercid), trimethoprim/sulfamethoxazole, and doxycycline.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/00019048-200203000-00016

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 395

Metadata

Authors
&NA;
Venue
Infectious Diseases in Clinical Practice
Published
2002-03
Volume
11
Issue
3
Pages
163
ISSN
1056-9103 (ISSN-L)
OpenAlex
W4255854804
Cited by
395
References
0
FWCI
16.11
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: STAPHYLOCOCCUS AUREUS RESISTANT TO VANCOMYCIN???UNITED STATES, 2002. https://app.cochat.ai/papers/10.1097/00019048-200203000-00016
The paper
&NA;. (2002). STAPHYLOCOCCUS AUREUS RESISTANT TO VANCOMYCIN???UNITED STATES, 2002. Infectious Diseases in Clinical Practice. https://doi.org/10.1097/00019048-200203000-00016

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.